Bristol and Nvidia unveil new drug research supercomputer

Bristol Myers Squibb and NVIDIA launched a giant supercomputer for life sciences aimed at accelerating drug development and reducing operational costs through advanced artificial intelligence technologies. The computer is built on the modern Nvidia DGX SuperPOD platform and is among the most powerful computers dedicated to the healthcare sector. This initiative is part of a three-year partnership between the two parties to enhance innovation capabilities and improve drug discovery processes.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل